Sanofi opens digital biologics manufacturing facility in US Farhat Nasim16 Oct 2019 9:45 AM ISTThe facility in Framingham accelerates the recent transformation of Sanofi's Industrial Affairs organization to focus on biologics-based therapies, in...
Allergan shareholders okays USD 63 billion AbbVie acquisition Medical Dialogues Bureau15 Oct 2019 9:30 AM ISTUnder the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity...
Cadila Healthcare largest API manufacturing site clears USFDA inspection Medical Dialogues Bureau12 Oct 2019 11:41 AM ISTThe US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
GSK collaborates with Lyell Immunopharma on cancer cell therapies Medical Dialogues Bureau12 Oct 2019 9:15 AM ISTCombining GSK plc's strong cell and gene therapy programmes with Lyell's technologies may allow the joint research team to maximize the activity and...
Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA Medical Dialogues Bureau11 Oct 2019 10:00 AM IST"The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility Medical Dialogues Bureau11 Oct 2019 9:15 AM ISTTorrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
Zydus Cadila gets USFDA nod for Colesevelam Hydrochloride tablets for lowering cholesterol Medical Dialogues Bureau10 Oct 2019 11:34 AM ISTZydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Colesevelam Hydrochloride tablets,...
Galderma wins USFDA nod for AKLIEF Cream to treat acne Medical Dialogues Bureau10 Oct 2019 9:30 AM ISTNew Delhi: Galderma, announced recently that the U.S. Food and Drug Administration (USFDA) has approved AKLIEF (trifarotene) Cream, 0.005% for the...
Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda Medical Dialogues Bureau9 Oct 2019 4:24 PM ISTJohnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
Amid cancer scare GSK recalls heartburn drug Zantac as precautionary measure Medical Dialogues Bureau9 Oct 2019 9:30 AM ISTGSK is recalling all unexpired stock of Zantac from pharmacies due to possible contamination with an impurity N-nitrosodimethylamine (NDMA), the...
JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030 Medical Dialogues Bureau7 Oct 2019 9:30 AM ISTNEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
Cipla gets 12 USFDA observations for Goa facility Medical Dialogues Bureau30 Sept 2019 3:15 PM IST"The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
